These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4271579)

  • 1. 5-Fluorouracil and derivatives in cancer chemotherapy. 3. In vivo enhancement of antitumor activity of 5-fluorouracil (FU) and 5-fluoro-2'-deoxyuridine (FUDR).
    Jato J; Windheuser JJ
    J Pharm Sci; 1973 Dec; 62(12):1975-8. PubMed ID: 4271579
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo antitumor effects of fluoropyrimidines on colon adenocarcinoma 38 and enhancement by leucovorin.
    Iigo M; Nishikata K; Hoshi A
    Jpn J Cancer Res; 1992 Apr; 83(4):392-6. PubMed ID: 1387127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of 2,2'-anhydro-5-ethyluridine, a uridine phosphorylase inhibitor, on the antitumor activity of 5-fluorouridine and 5-fluoro-2'-deoxyuridine.
    Iigo M; Nishikata K; Nakajima Y; Szinai I; Veres Z; Szabolcs A; De Clercq E
    Biochem Pharmacol; 1990 Apr; 39(7):1247-53. PubMed ID: 2138895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing effect of bromovinyldeoxyuridine on antitumor activity of 5'-deoxy-5-fluorouridine against adenocarcinoma 755 in mice. Correlation with pharmacokinetics of plasma 5-fluorouracil levels.
    Iigo M; Nishikata K; Nakajima Y; Hoshi A; Okudaira N; Odagiri H; De Clercq E
    Biochem Pharmacol; 1989 Jun; 38(12):1885-9. PubMed ID: 2525905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Fluorouracil and derivatives in cancer chemotherapy. II. Possible in vivo formation and stabilization of 5-fluoro-2'-deoxyuridine.
    Windheuser JJ; Jato J
    J Pharm Sci; 1972 Oct; 61(10):1669-70. PubMed ID: 4262850
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of deoxyuridine coadministration on toxicity and antitumor activity of fluorouracil and floxuridine.
    Jato JG; Lake LM; Grunden EE; Johnson BM
    J Pharm Sci; 1975 Jun; 64(6):943-6. PubMed ID: 124347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of a new fluoropyrimidine derivative, 5'-deoxy-5-fluorouridine, against murine and human experimental tumors.
    Fujimoto S; Wang Y; Inoue K; Ogawa M
    Jpn J Cancer Res; 1985 Jul; 76(7):644-50. PubMed ID: 3161854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The therapeutic effects of orally administered 5'-deoxy-5-fluorouridine, 1-(2-tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil on experimental murine tumors.
    Uehara N; Baba H; Nitta K; Kunimoto T; Takeuchi M; Sasaki T; Tanaka T
    Jpn J Cancer Res; 1985 Oct; 76(10):1034-41. PubMed ID: 2934356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the differential affinities of two anticancer analogues to their target.
    Holl E; Zänker KS; Lange J; Siewert JR
    Drugs Exp Clin Res; 1985; 11(2):133-9. PubMed ID: 2941256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative physiologic dispositions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil in mice bearing solid L1210 lymphocytic leukemia.
    Chadwick M; Chang C
    Cancer Treat Rep; 1976 Jul; 60(7):845-55. PubMed ID: 137772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antileukemic synergism between cyclophosphamide and an antitumor platinum compound.
    Walker EM; Gale GR
    Res Commun Chem Pathol Pharmacol; 1973 Sep; 6(2):419-25. PubMed ID: 4750093
    [No Abstract]   [Full Text] [Related]  

  • 12. Lack of effect of warfarin (NSC-59813) alone or in combination with 5-fluorouracil (NSC-19893) on primary and metastatic L1210 leukemia and adenocarcinoma 755.
    Higashi H; Heidelberger C
    Cancer Chemother Rep; 1971 Feb; 55(1):29-33. PubMed ID: 5121648
    [No Abstract]   [Full Text] [Related]  

  • 13. Enhancement of the antitumor activity of 5-fluorouracil by drug combinations.
    Frankfurt OS
    Cancer Res; 1973 May; 33(5):1043-7. PubMed ID: 4267349
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors.
    Garibjanian BT; Johnson RK; Kline I; Vadlamudi S; Gang M; Venditti JM; Goldin A
    Cancer Treat Rep; 1976 Sep; 60(9):1347-61. PubMed ID: 797450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of the antitumor action of 5-fluorouracil with 5-ethyl-2'-deoxyuridine in human colorectal tumor xenografts.
    Kopper L; Magyarosy E; Jeney A; Lapis K; Szabolcs A; Otvös L
    Oncology; 1984; 41(3):155-8. PubMed ID: 6328393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor effect and tumor level of 5-fluoro-2'-deoxyuridylate following oral administration of tetradecyl 2'-deoxy-5-fluoro-5'-uridylate.
    Nakajima Y; Iigo M; Hoshi A
    Anticancer Drugs; 1992 Jun; 3(3):289-92. PubMed ID: 1525410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation by acyclothymidine esters of the antitumor effect of orally administered 5-fluoro-2'-deoxyuridine esters on L1210 in mice.
    Kawaguchi T; Saito M; Saneyoshi M
    Jpn J Cancer Res; 1986 May; 77(5):436-9. PubMed ID: 2942523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of the antitumor effect of 5-fluoro-2'-deoxyuridine esters in combination with acyclothymidine esters on L1210 in mice via oral administration.
    Kawaguchi T; Saito M; Saneyoshi M
    J Pharm Sci; 1988 Nov; 77(11):939-43. PubMed ID: 2976090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of guanosine on antitumor activity of fluorinated pyrimidines against P 388 leukemia.
    Iigo M; Hoshi A
    Cancer Chemother Pharmacol; 1984; 13(2):86-90. PubMed ID: 6235977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of antitumor activity of 5-fluoro-2'-deoxyuridine by guanosine-5'-monophosphate.
    Iigo M; Hoshi A
    J Pharmacobiodyn; 1984 Jan; 7(1):67-9. PubMed ID: 6327964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.